Research Education Core
研究教育核心
基本信息
- 批准号:10684071
- 负责人:
- 金额:$ 13.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAcuteAddressAnimal Disease ModelsAreaBasic ScienceBiometryChronicClinical TrialsCommunitiesComplexDevelopmentDiverse WorkforceDrug ScreeningEducational ActivitiesEducational workshopEffectivenessEmergency responseEnvironmentEvaluationExposure toFacultyFeedbackFosteringFutureGenerationsGoalsGovernmentGrowthHuman ResourcesImageIndustryInnovative TherapyInstitutionInterdisciplinary StudyIntoxicationKnowledgeLaboratoriesLearningMedical StudentsMentorsMissionNeurologicNeurologyNeurosciencesOrganophosphatesOutcomeParticipantPatientsPharmaceutical ChemistryPharmacologyPharmacology and ToxicologyPostdoctoral FellowPreclinical TestingProcessResearchResearch ActivityResearch PersonnelResearch Project SummariesResearch TrainingResourcesScientistTherapeuticToxicologyTrainingTranslational ResearchUnderrepresented PopulationsUnited States National Institutes of HealthWorkcareerchemical threatcohortdesigndisadvantaged backgrounddrug developmentdrug discoveryeducation researcheffectiveness evaluationemergency preparednessequity, diversity, and inclusionexperiencegraduate studentimprovedinstructorlecturesmedical countermeasuremeetingsmembernervous system disorderneurotoxicologynext generationoutreachprogramsrecruitresponsible research conductrole modelskillssocioeconomic disadvantagesuccessundergraduate student
项目摘要
Project Summary – Research Education Core (REC)
The training of future leaders in the development of medical countermeasures for chemical threat agents is
critical to the success of the CounterACT program and to national emergency response and preparedness
efforts. The overall mission of the Research Education Core (REC) is to create a diverse array of human
resources capable of conducting team-based interdisciplinary research focused on addressing the complex
problems posed by chemical threat agents. Advanced training in pharmacology, toxicology, neuroscience, and
drug discovery will be provided to a diverse generation of researchers, more specifically, technicians, medical
and graduate students, postdoctoral fellows, and/or early stage investigators within and outside the UC Davis
CounterACT Center. Accordingly, the REC will interact with all Cores and Projects of the Center. A major
emphasis will be enhancing the diversity, and recruitment of trainees and mentors from underrepresented and
socioeconomically disadvantaged backgrounds into the Center.
The educational research environment at UC Davis is well suited for the CounterACT Center. UC Davis is a
national leader in pharmacology and toxicology, and CounterACT faculty have expertise in fundamental
pharmacology, toxicology, medicinal chemistry, drug screening, mechanistic target identification, animal models
of disease, advanced imaging, biostatistics as well as preclinical testing and participation in clinical trials. The
REC will facilitate the transfer of this knowledge to trainees and promote the advancement of trainees’ careers
by providing opportunities to be mentored by and learn from both internal and external scientists with expertise
relevant to the CounterACT mission.
The REC has three main objectives: (1) Develop skill sets necessary for the study of toxicology, pharmacology,
drug discovery, neuroscience, and neurological disorders related to chemical threat agents. First, hands-
on interdisciplinary and collaborative research training primarily in the laboratories of the Project and Core
Leaders will be provided. Second, specialized didactic training in areas relevant to the Center’s mission will be
accomplished via workshops, seminars, and specialized coursework. (2) Enhance the recruitment of graduate
students and faculty from underrepresented backgrounds into the UC Davis CounterACT Center by leveraging
well established undergraduate, graduate, and faculty STEM-related recruiting and retention programs on
campus. (3) Evaluate the activities of the REC to assess effectiveness and identify areas for improvement.
By fulfilling these objectives, the REC will accomplish its goal of developing a diverse group of scientists with
broader understanding of the concepts, challenges, and opportunities in drug discovery and development of
medical countermeasures of chemical threat agents.
项目摘要 - 研究教育核心(REC)
在为化学威胁代理商开发医学对策的未来领导者的培训是
对抵消计划的成功以及国家应急和准备的成功至关重要
努力。研究教育核心(REC)的总体使命是创建一系列人类
能够进行基于团队的跨学科研究的资源致力于解决综合体
化学威胁代理带来的问题。药理学,毒理学,神经科学和
更具体地说,技术,技术,医学,将提供药物发现
以及加州大学戴维斯分校内外的研究生,博士后研究员和/或早期舞台调查员
抵抗中心。据认为,REC将与中心的所有核心和项目互动。专业
重点将增强来自人为不足的学员和导师的多样性,并招募
社会经济上的背景进入中心。
加州大学戴维斯分校的教育研究环境非常适合抵抗中心。加州大学戴维斯分校是一个
药理学和毒理学的国家领导者以及反术的教师在基本方面具有专业知识
药理学,毒理学,医学化学,药物筛查,机械靶标识别,动物模型
疾病,晚期成像,生物统计学以及临床前测试和参与临床试验。
REC将有助于将这些知识转移给学员,并促进学员职业的进步
通过提供有机会召唤并向内部和外部科学家学习的机会,并具有专业知识
与抵抗任务有关。
REC具有三个主要目标:(1)开发研究毒理学,药理学,,
药物发现,神经科学和与化学威胁剂有关的神经系统疾病。首先,
主要在项目和核心实验室中的跨学科和协作研究培训
将提供领导者。其次,与中心任务相关的领域的专门教学培训将是
通过研讨会,半手和专业课程完成。 (2)增强毕业生的招聘
从代表性不足的背景的学生和教职
成熟的本科,研究生和教职员工与STEM相关的招聘和保留计划
校园。 (3)评估REC的活动以评估有效性并确定改进的领域。
通过实现这些目标,REC将实现与与
对药物发现和开发中的概念,挑战和机遇的更广泛理解
化学威胁代理的医学对策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gene Gabriel Gurkoff其他文献
Gene Gabriel Gurkoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gene Gabriel Gurkoff', 18)}}的其他基金
Project 3: Normalization of Neuronal Excitability
项目 3:神经元兴奋性正常化
- 批准号:
10684091 - 财政年份:2022
- 资助金额:
$ 13.6万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
- 批准号:
10752090 - 财政年份:2023
- 资助金额:
$ 13.6万 - 项目类别:
Targeting microglial cell iron-handling in Alzheimer’s Disease
靶向阿尔茨海默病中的小胶质细胞铁处理
- 批准号:
10603992 - 财政年份:2023
- 资助金额:
$ 13.6万 - 项目类别:
FORUM ON MEDICAL AND PUBLIC HEALTH PREPAREDNESS FOR DISASTERS AND EMERGENCIES AND ACTION COLLABORATIVE ON DISASTERS/PUBLIC HEALTH EMERGENCY RESEARCH
灾害和紧急情况医疗和公共卫生防备论坛以及灾害/公共卫生紧急情况研究行动合作
- 批准号:
10937101 - 财政年份:2023
- 资助金额:
$ 13.6万 - 项目类别:
Microphysiological Systems to Study Hypoxic Cardiac Injury
研究缺氧性心脏损伤的微生理系统
- 批准号:
10591258 - 财政年份:2023
- 资助金额:
$ 13.6万 - 项目类别:
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding
通过 Fc 效应子优化抗体抑制 MICA/B 脱落,增强对急性髓系白血病的免疫力
- 批准号:
10585146 - 财政年份:2023
- 资助金额:
$ 13.6万 - 项目类别: